February 8, 2018 / 6:30 AM / 14 days ago

BRIEF-Novartis gets U.S. approval for Cosentyx label Update

Feb 8 (Reuters) - Novartis AG:

* NOVARTIS RECEIVES FDA APPROVAL FOR COSENTYX® LABEL UPDATE TO INCLUDE MODERATE-TO-SEVERE SCALP PSORIASIS

* NOVARTIS RECEIVES FDA APPROVAL FOR COSENTYX® LABEL UPDATE TO INCLUDE MODERATE-TO-SEVERE SCALP PSORIASIS

* SAYS ‍THIS FOLLOWS A SIMILAR EUROPEAN LABEL UPDATE IN JUNE​ Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below